CONTACT | Print Page | Sign In | Join
2017 Conference Agenda
Share |

 The 2017 Conference Agenda included an impressive lineup of industry experts.

Sunday 10/15/17
2:30 PM - 4:00 PM Chapter Leadership Meeting 
3:30 PM - 7:00 PM  Exhibitor Setup 
3:00 PM - 7:00 PM  Registration Open 
5:00 PM - 7:00 PM  Welcome Reception 
 Monday 10/16/17
8:00 AM - 6:30 PM  Registration Open  
7:30 AM - 8:30 AM 

Breakfast with Exhibitors

8:30 AM - 6:00 PM  1:1 Partnering  
8:30 AM - 9:35 AM 

General Session 1: Welcome with Keynote Speaker


    Conference Welcome
Nancy K. Bryan, President & CEO, BioFlorida
    Mayor Rick Kriseman, Mayor of St. Petersburg

    Keynote - Think Big
    Jennifer Arnold, MD, M.Sc., FAAP, Medical Director of Simulation Center, Johns Hopkins All  
    Children's Hospital and star of TLC's "Little Couple"

9:35 AM - 9:50 AM   Break
9:55 AM - 11:10 AM  Breakout Session 1

   BioScience Track Session
   Diabetes: From Bench to Bedside
   Raymond Carr, Founder and Chief Technology Officer, Occam Technology Group (moderator)
   Karen Corbin, PhD,
Investigator, Translational Research Institute for Metabolism and Diabetes

   Felipe Echeverri, Managing Director, Biorep Technologies
   Norma Sue Kenyon, PhD,
Professor of Surgery & Vice Provost for Innovation, University of Miami

   BioBusiness Track Session
   Spotlight on Innovation
   Karen Moore, Founder and CEO, Moore Communications Group (moderator)
   Suzanne Bakewell, PhD, 
Vice President of Preclinical Development, Intezyne Technologies
   Steve Parkinson, 
President and CEO, Lakewood-Amedex, Inc.
   Glynn Wilson, PhD,
Chairman and Strategic Advisor, TapImmune, Inc.
   Hing Wong, PhD, CEO, Altor BioScience

   Session Sponsored By:

11:10 AM - 11:35 AM   Break 
11:40 AM - 12:55 PM  Breakout Session 2

     BioScience Track Session
     Marine Biotechnology: The Next Frontier 
     Commissioner Clifford R. Merz, PhD, PE, COMPS Program Director, University of South

     Bill J. Baker, PhD, Professor of ChemistryUniversity of South 
     Pravin R. Chaturvedi, PhD,
Co-Founder and CEO, Oceanyx Pharmaceuticals 
     Kevan L. Main, PhD,
Senior Scientist and Director, Mote Aquaculture research Park, Mote
     Marine Laboratory
     Anton Post, PhD,
 Executive Director, Florida Atlantic University - Harbor Branch Research Pillar

     BioTrends Track Session
     Breakthrough Research in Oncology

     James Mulé, PhD, Associate Center Director of Translational Science, Moffitt Cancer Center
     Paul A. Bertin, PhD, Vice President of Chemistry, Vybyl, Inc.
     Douglas W. Calder, 
President, Vycellix, Inc.           
     Patricia Lawman, PhD, 
CEO, Morphogenesis, Inc.
     Cosme Ordoñez MD, PhD,
  Managing Director of Healthcare Investment Banking, Noble Life

     Alexander Parker, PhD,
 Professor of Epidemiology & Urology Associate Director of Center for
     Individualized Medicine, Mayo Clinic 
     Ray Yin, PhD, CEO, ANP Technologies, Inc.

     BioBusiness Track Session 
     Next Generation Technology
     Laura M. Holm, Partner, Fox Rothschild LLP (moderator)
     Daniel Hahn,
Senior Business Development Associate, Medtronic
     Stuart Jones, 
President and CEO, BioLife, LLC
     Matthew H.J. Kim, Founder, Vigilant Biosciences and Principal of IP Guidance Ventures
     Maha Sallam, PhD,
President, VuEssence, Inc.
     Session Sponsored By: 


1:00 PM - 3:10 PM 

General Session 2 with Lunch: Keynote & Panel

     Presentation of "Company of the Year" Award
Keynote - The State of Health in Florida 
     Celeste Philip, MD, MPH, Florida Surgeon General and Secretary of Health,        
 Department of  Health

     Keynote - Future of Enterprise Florida 
     Tim Vanderhoof,
Senior Vice President of Business Development, Enterprise Florida

     Cybersecurity: What We Should Know
     Sri Sridharan
Director, Florida Center for Cybersecurity, University of South Florida (moderator)
     Jeremy Rasmussen,
Cybersecurity Director & CTO, Abacode           
     Paul Vitchock, Supervisory Special Agent - Cyber, Federal Bureau of Investigation, Tampa

 3:00 PM - 5:15 PM   Closed Door Sessions
3:10 PM - 3:20 PM  Break 
3:20 PM - 4:35 PM  Breakout Session 3

     BioScience Track Session
     Orphan Drugs: Development Trends and Commercial Strategies
     Jeff Tate, PhD,
COO and CSO, CTD Holdings, Inc. (moderator)
Jean-François Rossignol, PhD, FRSC, MD, FRCPath, HonFFPM, Chief Medical & Science
     Officer, Romark, L.C. 

     Frederick D. Sancilio, MS, PhD
, Founder, Chairman, President and CEO, Sancilio & Company,
Karla Beckner White, Director, State Government Affairs, CSL Behring
     BioTrends Track Session
     Bridge to the Patient
     Gina Alexis, Founder and President, The Alexis Group Consultants (moderator)
     Jennifer Arnold, MD, M.Sc., FAAP, 
Medical Director of Simulation Center, Johns Hopkins All 
     Children's Hospital and star of TLC's "Little Couple"

     Patrick C. Hardigan, PhD,
Professor of Public Health, Nova Southeastern University
     Greg Hindahl, MD,FAAFP,
Vice President and Chief Medical Information Officer, BayCare 
     Health System   

     Session Sponsored By:  

     BioBusiness Track Session

     Preparing for Commercialization: Keys to Success
     Quang Pham, Chairman and CEO, Espero BioPharma (moderator)
     Neil Goldenberg, MD, PhD, Associate Professor of Pediatrics, Division of Hematology, Johns   
     Hopkins University School of Medicine; Director of Research, Johns Hopkins All Children's 
     Glenn P. Ladwig,
Partner, Saliwanchik, Lloyd & Eisenschenk, P.A.
     Tony Lanzone, Managing Director,
INC Research/inVentiv Health Consulting
     Dawn N. Norman, MS
, Executive Vice President, MRC-X, LLC

4:35 PM - 4:55 PM  Break 
4:55 PM - 5:55 PM  CEO Forum, Research Forum & Incubator Forum
6:30 PM - 8:00 PM  Evening Reception 
 Tuesday 10/17/17
7:30 AM -  2:00 PM Registration 
8:00 AM - 2:00 PM  1:1 Partnering 
8:00 AM - 9:00 AM  Members Only: Government Affairs Committee Meeting  
8:00 AM - 9:00 AM  Breakfast with Exhibitors 
9:10 AM - 11:25 AM  General Session 4: BioPitch Finals & Panel


    BioPitch Finals
    Valerie Landrio McDevitt, JD, CLP, RTTP,
Associate Vice President, Technology Transfer &
    Business Partnerships, University of South Florida (moderator)

    Executive Perspective: How to Build your Business in Florida
Jim O'Connell, Assistant Vice President of Technology Commercialization, Director of
    Technology Transfer, University of Florida (moderator)
Lee H. Evans, Executive Director and Head North America Capability Center and Global
    Strategic Center Operations, Bristol-Myers Squibb
Robert Finizio, CEO, TherapeuticsMD
 Quang Pham, Chairman and CEO, Espero BioPharma
    Stephen W. Potter, Chief Business Officer, AGTC
Christopher Prentice, COO and CEO, Mazor Robotics, Inc.

    Patient Perspective
    Introduction by: Mark Strong, RN, CPTC
, Senior Vice President/Associate Executive Director,
    LifeLink Tissue Bank
    Patient: Michael Robinson 

11:25 AM - 11:45 AM   Break 
11:45 AM - 1:00 PM  Breakout Session 4

     BioScience Track Session
     Florida's Advancements in Regenerative Medicine
     Claudia Zylberberg, PhD, CEO, Akron Biotech (moderator)
     John P. Engels, Founder, AxoGen           
     Jon Dobson, PhD, Professor, University of Florida            
     Adil Duru, PhD, Assistant Professor, Nova Southeastern University Cell Therapy Institute        

 Track Session
     Partnering for Success

     Jarett Reiger, Esq., MBA, Senior Director, Innovation & Industry Alliances, Associate General
     Counsel, Moffitt Cancer Center (moderator)

     Richard A. Houghten, PhD, Founder and CEO, Torrey Pines Institute for Molecular Studies
     Warren Marcus, PhD, Research & Development Scientist/Business Development
     Associate, Altor BioScience Corporation
     Stephen W. Potter, 
Chief Business Officer, AGTC
     Glynn Wilson, PhD,
 Chairman & Strategic Advisor, TapImmune, Inc. 

 Track Session
     Expert Advice on Funding
     David L. Day, Executive Director, Southeast BIO (moderator)
     Andrew Danielsen, Vice Chair, Mayo Clinic Ventures 
     Jackson Streeter, MD, CEO, Florida Institute for the Commercialization of Public Research         

     Jonelle Toothman, Co-Founder and CEO, NeXtGen Biologics, Inc. 
     Scott E. Weiner,
 Partner, Pappas Ventures 

     Session Sponsored By:         

1:00 PM  Box Lunch 
About BioFlorida

BioFlorida is the voice of Florida's life sciences industry, representing 6,700 establishments and research organizations in the BioPharma, MedTech, HealthIT & BioAg that collectively employ nearly 94,000 Floridians.